Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Neven

Showing results (71-80 of 383) with videos related to

Pageof 39
Sort By:
Gynecologic Oncology|August 22, 2006
Transition of endometrial stromal sarcoma into high-grade sarcomaFrederic Amant, Heidi Woestenborghs, Vanessa Vandenbroucke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2013
Reply to D. Crivellari et alSileny N Han, Sibylle Loibl, Ben Van Calster, et al.
Breast (Edinburgh, Scotland)|April 25, 2022
Validation of a prognostic scoring system for postmastectomy locoregional recurrence in breast cancerAline Van der Vorst, Isabelle Kindts, Annouschka Laenen, et al.
Gynecologic Oncology|April 26, 2002
The effect of raloxifene on the incidence of ovarian cancer in postmenopausal womenPatrick Neven, Steven R Goldstein, Angelina V Ciaccia, et al.
Current Treatment Options in Oncology|June 3, 2015
The UZ Leuven Policy for Extended Adjuvant Anti-estrogen Therapy in Women With Early Estrogen Receptor-Positive Breast CancerKathleen Van Asten, An Poppe, Kevin Punie, et al.
Cancers|January 10, 2026
Patient Preferences in Breast Cancer: A Scoping ReviewCharlotte Verbeke, Fiene Schuermans, Fien Vanopré, et al.
Menopause (New York, N.Y.)|February 18, 2011
Undetectable antimüllerian hormone levels and recovery of chemotherapy-induced ovarian failure in women with breast cancer on an oral aromatase inhibitorAnne-Sophie Dieudonné, Johan Vandenberghe, Inge Geerts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2008
Value of positron emission tomography of the para-aortic lymph nodes in cervical carcinoma stage IB2-IIIBIgnace Vergote, Dimitris Tsolakidis, Dieter Mortier, et al.
The Oncologist|May 2, 2008
Intraperitoneal chemotherapy in patients with advanced ovarian cancer: the con viewIgnace Vergote, Frederic Amant, Karin Leunen, et al.
Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer|May 16, 2024
Navigating next-generation HR<sup>+</sup>/HER2<sup>-</sup> metastatic breast cancer therapies: a critical commentary on abemaciclib <i>vs.</i> tucidinostat after palbociclib progressionPatrick Neven, Lieke Dullens, Sileny Han, et al.
Pageof 39

Showing results (71-80 of 383) with videos related to

Sort By:
Pageof 39
Gynecologic Oncology|August 22, 2006
Transition of endometrial stromal sarcoma into high-grade sarcomaFrederic Amant, Heidi Woestenborghs, Vanessa Vandenbroucke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2013
Reply to D. Crivellari et alSileny N Han, Sibylle Loibl, Ben Van Calster, et al.
Breast (Edinburgh, Scotland)|April 25, 2022
Validation of a prognostic scoring system for postmastectomy locoregional recurrence in breast cancerAline Van der Vorst, Isabelle Kindts, Annouschka Laenen, et al.
Gynecologic Oncology|April 26, 2002
The effect of raloxifene on the incidence of ovarian cancer in postmenopausal womenPatrick Neven, Steven R Goldstein, Angelina V Ciaccia, et al.
Current Treatment Options in Oncology|June 3, 2015
The UZ Leuven Policy for Extended Adjuvant Anti-estrogen Therapy in Women With Early Estrogen Receptor-Positive Breast CancerKathleen Van Asten, An Poppe, Kevin Punie, et al.
Cancers|January 10, 2026
Patient Preferences in Breast Cancer: A Scoping ReviewCharlotte Verbeke, Fiene Schuermans, Fien Vanopré, et al.
Menopause (New York, N.Y.)|February 18, 2011
Undetectable antimüllerian hormone levels and recovery of chemotherapy-induced ovarian failure in women with breast cancer on an oral aromatase inhibitorAnne-Sophie Dieudonné, Johan Vandenberghe, Inge Geerts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2008
Value of positron emission tomography of the para-aortic lymph nodes in cervical carcinoma stage IB2-IIIBIgnace Vergote, Dimitris Tsolakidis, Dieter Mortier, et al.
The Oncologist|May 2, 2008
Intraperitoneal chemotherapy in patients with advanced ovarian cancer: the con viewIgnace Vergote, Frederic Amant, Karin Leunen, et al.
Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer|May 16, 2024
Navigating next-generation HR<sup>+</sup>/HER2<sup>-</sup> metastatic breast cancer therapies: a critical commentary on abemaciclib <i>vs.</i> tucidinostat after palbociclib progressionPatrick Neven, Lieke Dullens, Sileny Han, et al.
Pageof 39